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The cytoplasmic granules of bovine neutrophils naturally possess 
indolicidin - a promising cationic antimicrobial peptide as it displays inherent inhibi-
tory activities against a broad type of microbial pathogens. In this study, a shake flask 
level production and expression optimizations of the indolicidin by the recombinant 
Escherichia coli C41 (DE3) clones (transformed with pET21a(+) plasmid carrying indolici-
din gene) were carried out under standard conditions, as to determine the conditions 
required for maximal production. It was determined that a concentration of 1 mM of 
IPTG was effective, the 2×YT with salts and LB media at pH 7.5 with 3-6 h of incubation 
were required for maximal indolicidin expression.






















The increasing prevalence of drug resistant and multi-
drug resistant bacteria has prompted to investigate and 
produce new compounds against bacterial pathogens as 
an intervention to ensure efficient infection control mea-
sures (Ahmad et al. 1995). Cationic antimicrobial peptides 
(CAPs) represent an exciting class of drug candidates, 
particularly because their mechanism of action is unlikely 
to induce drug resistance. As a kind of humoral immune 
response, such host defense peptides are synthesized by a 
wide range of multicellular organisms including bacteria 
and protect against a wide range of infectious bacteria, 
viruses, fungi and certain parasites (Zhang and Gallo 
2016). Precisely, they are endogenous peptide antibiotics 
forming important components of the innate immune sys-
tem (Hancock et al. 2006) of vertebrates and invertebrates. 
Thus, CAPs can be developed and potentially employed 
in medicine as new safe antibacterial compounds.
The cationic antimicrobial peptide - indolicidin is a 
13-residue peptide (measures less than 2.8 kDa in size) 
and carries five tryptophan residues that distinguish 
it from α-helical and β-structured cationic peptides. 
It is isolated from the cytoplasmic granules of bovine 
neutrophils possessing a unique amino acid composi-
tion (ILPWKWPWWPWRR-NH2-H-Ile-Leu-Pro-Trp-
Lys- Trp-Pro-Trp-Trp-Pro-Trp-Arg-Arg-NH2) with 39% 
tryptophan, 23% proline, and an amidated carboxyl ter-
minus. The molecular weight of the indolicidin peptide 
was reported to be 2861 Da with a total of 20 amino acids 
(MHHHHHHILPWKWPWWPWRR) including ̀ His’-Tag 
and the start codon. Indolicidin has been noted to be a 
promising agent since it could target a variety of bacte-
rial and fungal pathogens. It exhibits broad-spectrum 
antimicrobial activity in vitro against Gram positive 
(Staphylococcus aureus) and Gram negative (Escherichia coli) 
bacteria, fungi (Aspergillus fumigatus, Candida albicans and 
Cryptococcus neoformans), protozoa (Leishmania donovani), 
and human immunodeficiency virus (HIV-1) (Ahmad et 
al. 1995; Selsted et al. 1992; Benincasa et al. 2006; Lee et 
al. 2002; Bertrand-Krajewski et al. 2005). It also possesses 
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haemolytic and cytotoxic activities towards erythrocytes 
and human T lymphocytes (Schluesener et al. 1993). De-
spite the small size and unique composition of indolicidin, 
it is capable of killing bacteria, by causing disruption of 
the cytoplasmic membrane by channel formation.
The advent of recombinant DNA technology has 
conquered the traditional problems of protein research 
including purification of minute homogenous quantities 
of desired peptides from tissues (Alberts et al. 1994). It 
enables isolation of specific genes and to perpetuate them 
in host organisms besides ensuring higher expression 
and purity of the compound, safety, decreased cost of 
production (WHO 2014). Accordingly, many different 
host/vector systems are being developed to produce 
antimicrobial peptides through recombinant DNA tech-
nology. E. coli C41 (DE3) and C43 (DE3) strains have been 
employed most often due to the low cost of fermentation/
expression compared to mammalian cells, and its ability 
to produce inclusion bodies, which aid in the purification 
process (Haught et al. 1998; Lee et al. 1998). Industrial 
biotechnology uses recombinant microbes for produc-
ing a commercial product like indolicidin in stages of 
upstream processing (preparation of raw material/media 
for fermentation), fermentation (growth of the target 
microorganism in a large bioreactor with the consequent 
production of a desired compound) and downstream 
processing (purification of the desired compound (Glick 
and Pasternak 1998). The present evaluation has majorly 
focused on the maximal expression and optimization of 
indolicidin production by the recombinant E. coli C41 
(DE3) clone that was earlier cloned in the study to express 
indolicidin.
Materials and Methods
Competent E. coli C41 (DE3) cells (Lucigen, USA) were pre-
pared and transformed with the pET-21a (+) recombinant 
plasmids (Fig. 1). The optical density (OD)  checked trans-
formed cells were subsequently assessed to optimize in-
dolicidin expression with (flasks A & B) and without (flask 
C) 1 mM IPTG (isopropyl β-D-1-thiogalactopyranoside) 
induction. After everyone hour, 1 ml of culture was with-
drawn from each flask to check the OD and indolicidin 
expression (Froger and Hall 2007).
Confirmation of indolicidin expression by the recombi-
nant E. coli
Tricine sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (tricine-SDS-PAGE) was employed for 
the separation and confirmation of indolicidin. A 20% 
separating gel (1 cm length) followed by 16% separating 
gel (5 cm length) was overlaid with 10% ‘spacer gel’ (to 
considerably sharpen the bands for proteins and peptides 
of 1-5 kDa). The electrophoresis was started after loading 
10 μL of the prepared samples at 90 V. After separation, 
the protein was visualized by directly staining the gel by 
Coomassie Brilliant Blue (Schägger and von Jagow 1987; 
Schägger 2006). The culture from A & B flasks (induced) 
were centrifuged, before and after induction for 10 min, 
10 000 rpm at 4 °C. The supernatants were discarded, 
and the samples of each cell pellet were normalized at 
appropriate OD, boiled and run on two sets of 16% tris-
tricine gels simultaneously. The gels were suitably stained, 
destained and visualized. The un-induced samples (from 
the flask C) were also subjected to tricine-SDS-PAGE. The 
samples possessing the expressed indolicidin of the study 
were screened for their antimicrobial activity against a set 
of bacterial pathogens along with un-inoculated media 
samples as controls so as to determine the presence and 
antimicrobial activities of the expressed indolicidin of 
the study.
Effect of the inducer - IPTG on indolicidin production by 
the recombinant E. coli
A contaminant free, confirmed E. coli clone was involved 
in all the optimization studies. The E. coli culture (OD600 
value of 1.5 - 2.5) in LB medium was induced with dif-
ferent concentrations (0.5 mM, 1.0 mM, 2 mM, 5 mM, 
and 10 mM) of the IPTG and were incubated at 37 °C in 
duplicates. Pre and post induction samples were collected 
and were analyzed quantitatively and qualitatively by 
electrophoresis.
Primary screening of production media - shake flask 
studies
A total of eight different media (nutrient broth, min A, 
Luria Bertani medium, 2×YT medium, 2×YT with salts, 
Figure 1. pET-21a (+) expression vector map showing the restriction sites, 
the gene insert (indolicidin), selectable marker [bla (Ap)] and the origin of 
replications (f1 origin & ColE1-EMD Biosciences). Gene insert: Indolicidin; 
Host: E. coli K12 XL10 gold (dam+ dcm+); Gene size: 63 bp. Vector backbone: 
pET-21a (+) Cloning sites: XbaI/XhoI
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terrific broth (TB) medium, SB medium & SOB medium 
(Himedia, India) containing varying concentrations of 
tryptone, yeast extract with different carbon sources like 
glycerol, glucose and with several salts/buffer combina-
tions were involved in the preliminary screening of a 
best medium for expression (Sambrook and Russel 2001). 
Similarly, 1 ml of 100 mg/mL sterile filtered ampicillin 
was added just before inoculation, 0.5 mL stock culture 
was inoculated, and all the studies were executed at shake 
flask level (with 50 ml of the test medium in a 250 ml flask).
To prepare the inoculum for shake flask studies, 0.5 
mL of stock culture was inoculated into 50 mL of LB-
Amp medium after thawing and incubated at 37 °C, 200 
rpm for overnight. From the overnight culture, 5 mL of 
culture was inoculated into the shake flasks of different 
media (100 mL) with ampicillin and incubated at 37 °C, 
200 rpm. The induction was carried out using 1 mM 
IPTG at 1.0 ± 0.2 OD after obtaining the desired cell OD. 
One mL of IPTG induced (also normalized to 10 OD600) 
culture sample was taken from each flask for 3 h (while 
a sampling was also done just before induction). The 
indolicidin peptide expression was checked for both the 
induced as well as the uninduced cell samples after lysis 
by tricine SDS-PAGE.
Effect of different pH on indolicidin production by the 
recombinant E. coli
In order, to study the effect of media pH on indolicidin 
production, initial media pH was adjusted ranging from 
6 to 9 with an increment of 0.5 unit (6, 6.5, 7, 7.5, 8, 8.5 
and 9). The experiment was carried out using LB media 
(with optimized amount of ingredients) in duplicates and 
indolicidin was extracted after 12 h of incubation and 
estimated for indolicidin activity.
Effect of incubation time on indolicidin production by 
the recombinant E. coli
The indolicidin production media was prepared in dupli-
cates with all optimized parameters and inoculated with 
the E. coli. The indolicidin assay was carried out from the 
8th h incubation up to 32 h after every 4 h interval (i.e. 8, 
12, 16, 20, 24, 28, and 32 h) of incubation.
Effect of temperature on indolicidin production by the 
recombinant E. coli
The incubation - temperature at various ranges (25, 
30, 37, 40 and 45 °C) was evaluated and optimized to 
support a better expression of the indolicidin peptide 
by the recombinant E. coli of the study. Developmental 
batches were executed at 250 mL flasks with 50 mL of 
LB medium in duplicates inoculated with the test E. coli 
and were incubated at room temperature as well as at 
30, 37, 40 and 45 °C appropriately (Shokri 2003; Schmidt 
2005). Precisely, all the indolicidin fermentation processes 
included simultaneous gearing up of the growing cells to 
produce the indolicidin protein by inducing them with 
1 mM IPTG so that the cellular machinery was mostly 
engaged in expressing the target protein(s) in abundance 
from of the start of the inoculation. Finally, the fermen-
tation medium was separated by harvesting the cells, 
concentrated and then evaluated for the target peptide.
Results
In this study, the LB-Amp plates incubated with transfor-
mation mixes of host E. coli C41 (DE3) cells and pET-21a (+) 
(EMD Biosciences, USA) with indolicidin gene construct 
showed a good growth of individual, isolated colonies after 
overnight incubation. The transformation efficiency was 
found to be 2.2 × 105 CFU/ng of DNA. The OD values of 
E. coli transformants grown in flasks A & B (with IPTG 
induction), and flask C (no IPTG induction) at different 
intervals both before and after induction with the inducer 
indicated a difference in expression between the IPTG 
induced and non-induced clones. The SDS-PAGE analysis 
done for the culture sampled from the flask cultures A 
& B of the induced clones confirmed the expression of 
2.8 kDa indolicidin peptide as a discrete band at the bot-
tom of the gel (Fig. 2) and the expressed peptide was also 
quantified by densitometry along with a standard. The 
expression of the peptide by the transformed cells was 
also confirmed after growing the preliminarily confirmed 
transformants in shake-flask cultures and was also found 
that the induction of recombinant protein (indolicidin) 
in E. coli cultures could be best obtained when induced 
Figure 2. Tricine - SDS-PAGE profile of indolicidin expression check of 10 
OD normalized E. coli transformants. Band representing the target peptide 
- indolicidin measuring 2.8 kDa.
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at OD600value of 0.6 to 1.0.
The standardization of parameters governing the 
growth of recombinant E. coli C41 (DE 3) and production 
of indolicidin in high yields were studied at shake flask 
level. The effect of various media, different concentrations 
of IPTG inducer, suitable temperature, pH of the media, 
incubation duration brought useful outcomes. Of the 
eight different media [Nutrient broth, Min A, LB medium, 
2×YT medium, 2×YT with salts, Terrific Broth (TB) me-
dium, SB medium and SOB medium] containing varying 
concentrations of tryptone, yeast extract with different 
carbon sources like glycerol, glucose and with several 
salts/buffer combinations involved in the preliminary 
screening, it was apparent that the growth of E. coli was 
higher 2×YT with salts, TB medium and in LB medium 
with elevated levels of OD compared to other media. SOB 
medium was noted to be the least in supporting E. coli 
growth. Similarly, a difference in indolicidin expression 
by the E. coli clone was noted when grown in different 
media as the OD obviously varied when determined both 
before and after IPTG induction (Table 1). Although, each 
medium supported high yield of indolicidin, the 2×YT with 
salts, TB medium and LB media were found to support 
higher expressions especially after induction with IPTG. 
In addition, the difference in indolicidin expression was 
also evaluated using SDS-PAGE. It was observed that in 
the presence of 2×YT with salts and LB media as much 
as 101 mg/L and 90 mg/L of indolicidin was estimated, 
respectively after four hours from the time of induction.
Discussion
The alarming development of microbial drug resistance 
has resulted in intensive research and development of 
alternate antimicrobial compounds in order, to main-
tain a pool of effective therapeutic agents in real times 
so as to combat microbial infections. More importantly, 
these new antimicrobials should preferably possess both 
unique modes of action as well as different cellular targets 
compared with the existing antibiotics. Accordingly, good 
efforts have been made to develop cationic antimicrobial 
peptides as drugs since they possess broad spectrum 
ability in killing microbes and act non-specifically by 
targeting the sites for which development of resistance 
is difficult. In this line, the peptides like indolicidin is an 
attractive subject for drug research and hence there has 
been a lot of commercial interest and effort in develop-
ing indolicidin as a potential antimicrobial therapeutic. 
Though, a large number of antimicrobial peptides have 
been found in nature and been designed, relatively a few 
have been investigated for their clinical trials based on 
their promising in vitro and animal studies.
After selection of the expression vector [pET-21a (+)] 
of the study, several different host strains were identified 
[E. coli C41DE3 derivative of BL21 (Lee et al. 1998; Ponti 
et al. 1999), HS174DE3 (Lee et al. 2000), BL21DE3 and 
AD494DE3 (Morin et al. 2006) and JM109 (Taguchi et 
al. 1994)] from literature and was noted that two mutant 
strains of E. coli BL21 (DE3), C41 (DE3) and C43 (DE3) 
were frequently used to overcome the toxicity associated 
with over expressing recombinant proteins using the 
bacteriophage T7 RNA polymerase expression system. 
The strains were also reported with properties of proteo-
lytic deficiencies, solubilization of recombinant proteins, 
or derivation from different cell strains (Miroux and 
Walker 1996; Dumon-Seignovert et al. 2004). Miroux and 
Walker (1996) further reported that by using E. coli C41 
(DE3), cell death during induction of the host could be 
avoided. Further, E. coli has been used successfully for the 
higher expression of several recombinant antimicrobial 
peptides like lactoferricin (Feng et al. 2006; Kim et al. 
1997), calmodulin (Zheng et al. 1997), CM4 (Zhou et al. 
2009) and human beta-defensin 2 (Xu et al. 2006). As has 
been observed in the present study, Wagner et al. (2008) 
reported that E. coli C41 (DE3) strain is acceptable for 
convenient over expression of any given novel protein 
such as indolicidin.
Haught et al. (1998) and Skosyrev et al. (2003) reported 
a growth maximum of 1.5 OD. Other researchers had 
reported expression of 0.1 to 310 mg/L of antimicrobial 
peptide (Haught et al. 1998; Lee et al. 1998; Skosyrev et al. 
2003; Hara and Yamakawa 1996; Lee et al. 2002; Hwang 
et al 2001). The major goal for optimizing production of 
recombinant proteins is to produce the highest amount 
of functional product per unit volume per unit time.
In this context, most of the work was only aimed at 
increasing recombinant protein production in bacterial 
strains by increasing the biomass production and studies 
on the expression of recombinant proteins based on the 
effects of media composition are minimal. Though Swartz 
(2001) and Balbás (2001) reported that the fermentation 
and the level of intracellular accumulation of a recom-
Test production media
OD600 (time of sampling)
JBI AI (2 h) AI (3 h) AI (4 h)
LB medium 0.82 1.73 2.16 2.74
SB medium 0.92 1.72 2.24 2.52
SOB medium 0.74 1.68 2.20 2.46
TB medium 0.86 1.92 2.65 3.00
2×YT medium 0.72 1.82 2.40 2.92
2×YT with salts 1.02 2.06 2.90 3.38
Table 1. Primary screening - pre and post induction OD patterns of indolicidin 
expressing E. coli clones in different production media.
AI - after induction; JBI - just before induction
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binant protein in E.coli is dependent on the final cell OD 
and the specific activity of the protein, it is also known 
that the production of secondary metabolites in microbial 
strains can depend on the composition of the medium in 
which the organism is grown and the expression of all 
proteins will be not maximal in one medium and it has 
to be optimized for specific proteins.
Despite this, little attention has been paid to the effects 
of medium formulation on the accumulation of recombi-
nant proteins (Broedel et al. 2001). As the industrial expres-
sion of the eukaryotic peptide - indolicidin is more at the 
developing stage, the present study included appropriate 
evaluations so as to formulate an effective medium for the 
maximal expression of indolicidin. While the available 
literature played a pivotal role, the prior knowledge on 
the aspect was of much help in formulating various test 
media of the study for indolicidin expression in E. coli. 
Further, the expression host of the study - E. coli C41 (DE3) 
that grew rapidly and at high cell densities on inexpensive 
substrates was an added advantage. Further, the total 
protein concentration in LB medium was estimated to 
be higher with 1 mM concentration of IPTG, while the 
same was noted to be insignificant with further increase 
in concentration of IPTG. Similarly, from the results 
obtained, it was evident that the growth rate or doubling 
time of the indolicidin clone (E. coli) was faster in 2×YT 
with salts, TB medium and LB medium with pH 7.5 at 37 
°C than at lesser temperatures, with an incubation ranging 
from 3-6 h towards a higher production of indolicidin 
when compared with other tested parameters (Table 2).
Conclusion
In this study, lab scale optimization of indolicidin expres-
sion determined the ideal parameters for maximal expres-
sion of the peptide by pET21a(+) recombinant plasmids in 
E. coli C41 (DE3). Against the fact that industrial produc-
tion optimization of any novel peptide usually preceded 
by lab scale production optimization, the outcomes of the 
present evaluation could be suitably employed during scale 
up events so as to maximize the indolicidin expression. 
Further, alternative drugs are viewed to be the remedies 
to redress the emerging microbial pathogens, and that 
other potent antimicrobial peptides could also be tried 
as to develop them in to promising drugs.
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